Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_978b32c7385f8b54b69a8db4e69ae6aa |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N5-163 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-00 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-577 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-395 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12P21-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N5-16 |
filingDate |
1980-10-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1c4338b52a4261965c244921abab7d56 |
publicationDate |
1981-05-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
EP-0028902-A1 |
titleOfInvention |
Method for the preferential formation of hybrid cells making a desired antibody |
abstract |
A method for the production of monoclonal antibodies is disclosed wherein cells are produced and isolated which are hybrid between specific antibody producing cells and myeloma cells having the antigen to the specific antibody on their surface. |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0164953-A3 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5001056-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0096839-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4833077-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0298280-A2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4695538-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0298280-A3 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-0042176-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0164953-A2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5789152-A |
priorityDate |
1979-11-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |